Go Deep
Kobayashi Pharmaceutical Co., Ltd.
Kobayashi Pharmaceutical Co., Ltd. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 20,812 | 324.5 | 2.53 | 0.00 | 4,318.07 |
| Oct 2026 | 20,849 | 328.1 | 2.52 | 0.00 | 4,289.26 |
| Oct 2026 | 21,002 | 322.3 | 2.46 | 0.00 | 4,175.62 |
Kobayashi Pharmaceutical Co., Ltd. Quarterly Results
| Line Item | Mar 2026 | Mar 2025 |
|---|---|---|
| EPS | 13.9 | 21.9 |
Kobayashi Pharmaceutical Co., Ltd. Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 165,742,000,000.0 | 165,600,000,000.0 | 173,455,000,000.0 | 166,258,000,000.0 | — |
| Net Profit | 3,656,000,000.0 | 10,067,000,000.0 | 20,338,000,000.0 | 20,022,000,000.0 | — |
| EPS | 49.2 | 135.4 | 268.2 | 259.6 | — |
Kobayashi Pharmaceutical Co., Ltd. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 275,329,000,000.0 | 265,368,000,000.0 | 267,473,000,000.0 | 255,827,000,000.0 | — |
| Total Liabilities | 64,321,000,000.0 | 51,898,000,000.0 | 62,657,000,000.0 | 57,928,000,000.0 | — |
| Total Equity | 210,999,000,000.0 | 213,466,000,000.0 | 204,816,000,000.0 | 197,899,000,000.0 | — |
Owes vs Owns
Kobayashi Pharmaceutical Co., Ltd. owed ¥0.17 for every ¥1 it owned in Jun 2026, down from ¥0.23 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.17× | 0.23× | 0.20× | 0.23× | 0.23× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Kobayashi Pharmaceutical Co., Ltd. Assets & Liabilities Breakdown (JPY millions)
What it owns — Dec 2025
Cash & short-term investments 25.6%Receivables 19.0%Inventory 8.3%Fixed assets (tangible) 24.5%Intangible assets 6.3%Long-term investments 11.6%Other assets 4.8%
How it's funded — Dec 2025
Payables 3.1%Other liabilities 20.0%Shareholders' equity 76.6%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 70,614.0 | 65,745.0 | 79,836.0 | 104,533.0 |
| Receivables | 52,180.0 | 49,442.0 | 53,028.0 | 47,881.0 |
| Inventory | 22,752.0 | 24,163.0 | 22,081.0 | 17,678.0 |
| Fixed assets (tangible) | 67,367.0 | 67,448.0 | 47,665.0 | 34,778.0 |
| Intangible assets | 17,414.0 | 20,674.0 | 21,614.0 | 13,307.0 |
| Long-term investments | 31,840.0 | 24,617.0 | 32,124.0 | 28,509.0 |
| Other assets | 13,162.0 | 13,279.0 | 11,125.0 | 9,141.0 |
| Liabilities & equity | ||||
| Short-term debt | 319.0 | 343.0 | 379.0 | 0.0 |
| Long-term debt | 359.0 | 503.0 | 608.0 | 531.0 |
| Payables | 8,458.0 | 8,264.0 | 8,745.0 | 9,051.0 |
| Other liabilities | 55,185.0 | 42,788.0 | 52,925.0 | 48,346.0 |
| Shareholders' equity | 211,008.0 | 213,470.0 | 204,816.0 | 197,899.0 |
| Net tangible assets | 193,585.0 | 192,792.0 | 183,202.0 | 184,592.0 |
Kobayashi Pharmaceutical Co., Ltd. Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | 25,590,000,000.0 | 11,246,000,000.0 | 18,360,000,000.0 | 31,914,000,000.0 | — |
| Investing Activities | -154,000,000.0 | -18,415,000,000.0 | -19,576,000,000.0 | -14,312,000,000.0 | — |
| Financing Activities | -7,921,000,000.0 | -7,768,000,000.0 | -19,463,000,000.0 | -20,759,000,000.0 | — |